179 related articles for article (PubMed ID: 35784362)
1. Humanized Anti-RGMa Antibody Treatment Promotes Repair of Blood-Spinal Cord Barrier Under Autoimmune Encephalomyelitis in Mice.
Hirata T; Itokazu T; Sasaki A; Sugihara F; Yamashita T
Front Immunol; 2022; 13():870126. PubMed ID: 35784362
[TBL] [Abstract][Full Text] [Related]
2. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
Front Immunol; 2022; 13():861486. PubMed ID: 35664003
[TBL] [Abstract][Full Text] [Related]
3. RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis.
Muramatsu R; Kubo T; Mori M; Nakamura Y; Fujita Y; Akutsu T; Okuno T; Taniguchi J; Kumanogoh A; Yoshida M; Mochizuki H; Kuwabara S; Yamashita T
Nat Med; 2011 Apr; 17(4):488-94. PubMed ID: 21423182
[TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine Protects Blood-Spinal Cord Barrier Integrity by Modulating Microglia Polarization Through Activation of STAT3/SOCS3 and Inhibition of NF-кB Signaling Pathways in Experimental Autoimmune Encephalomyelitis Mice.
Zhang L; Lu X; Gong L; Cui L; Zhang H; Zhao W; Jiang P; Hou G; Hou Y
Cell Mol Neurobiol; 2021 May; 41(4):717-731. PubMed ID: 32424774
[TBL] [Abstract][Full Text] [Related]
5. RGMa regulates CCL5 expression via the BMP receptor in experimental autoimmune encephalomyelitis mice and endothelial cells.
Tang S; Su B; Tao T; Yan W; Zhang R; Qin X; Feng J
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35029290
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.
Tanabe S; Fujita Y; Ikuma K; Yamashita T
Cell Death Dis; 2018 Oct; 9(11):1061. PubMed ID: 30333477
[TBL] [Abstract][Full Text] [Related]
7. Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models.
Huang L; Fung E; Bose S; Popp A; Böser P; Memmott J; Kutskova YA; Miller R; Tarcsa E; Klein C; Veldman GM; Mueller BK; Cui YF
Neurobiol Dis; 2021 Nov; 159():105492. PubMed ID: 34478849
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of repulsive guidance molecule-a ameliorates compromised blood-spinal cord barrier integrity associated with neuromyelitis optica in rats.
Katsu M; Sekine-Tanaka M; Tanaka M; Horai Y; Akatsuka A; Suga M; Kiyohara K; Fujita T; Sasaki A; Yamashita T
J Neuroimmunol; 2024 Mar; 388():578297. PubMed ID: 38306928
[TBL] [Abstract][Full Text] [Related]
9. Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis.
Kubo T; Tokita S; Yamashita T
J Neuroimmune Pharmacol; 2012 Sep; 7(3):524-8. PubMed ID: 22183806
[TBL] [Abstract][Full Text] [Related]
10. Repulsive guidance molecule-a is involved in Th17-cell-induced neurodegeneration in autoimmune encephalomyelitis.
Tanabe S; Yamashita T
Cell Rep; 2014 Nov; 9(4):1459-70. PubMed ID: 25456136
[TBL] [Abstract][Full Text] [Related]
11. Anti-repulsive guidance molecule-a antibody treatment and repetitive transcranial magnetic stimulation have synergistic effects on motor recovery after spinal cord injury.
Nakanishi T; Fujita Y; Tanaka T; Yamashita T
Neurosci Lett; 2019 Sep; 709():134329. PubMed ID: 31200090
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
[TBL] [Abstract][Full Text] [Related]
14. Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates.
Jacobson PB; Goody R; Lawrence M; Mueller BK; Zhang X; Hooker BA; Pfleeger K; Ziemann A; Locke C; Barraud Q; Droescher M; Bernhard J; Popp A; Boeser P; Huang L; Mollon J; Mordashova Y; Cui YF; Savaryn JP; Grinnell C; Dreher I; Gold M; Courtine G; Mothe A; Tator CH; Guest JD
Neurobiol Dis; 2021 Jul; 155():105385. PubMed ID: 33991647
[TBL] [Abstract][Full Text] [Related]
15. Absence of endothelial α5β1 integrin triggers early onset of experimental autoimmune encephalomyelitis due to reduced vascular remodeling and compromised vascular integrity.
Kant R; Halder SK; Bix GJ; Milner R
Acta Neuropathol Commun; 2019 Jan; 7(1):11. PubMed ID: 30678721
[TBL] [Abstract][Full Text] [Related]
16. Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway.
Echeverry S; Shi XQ; Rivest S; Zhang J
J Neurosci; 2011 Jul; 31(30):10819-28. PubMed ID: 21795534
[TBL] [Abstract][Full Text] [Related]
17. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
Nathoo N; Agrawal S; Wu Y; Haylock-Jacobs S; Yong VW; Foniok T; Barnes S; Obenaus A; Dunn JF
Mult Scler; 2013 May; 19(6):721-31. PubMed ID: 23027879
[TBL] [Abstract][Full Text] [Related]
19. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric magnetic resonance imaging for detection of pathological changes in the central nervous system of a mouse model of multiple sclerosis in vivo.
Althobity AA; Khan N; Sandrock CJ; Woodruff TM; Cowin GJ; Brereton IM; Kurniawan ND
NMR Biomed; 2023 Oct; 36(10):e4964. PubMed ID: 37122101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
